MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dysarthria"

  • 2022 International Congress

    Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson’s disease: the PD COMM randomised controlled trial.

    C. Sackley, C. Rick, S. Patel, R. Woolley, M. Brady, A. Nicoll, S. Dickson, G. Beaton, C. Smith, H. Nankervis, C. Burton, P. Masterson-Algar, N. Ives, S. Jowett, Z. Abdali, L. Sharp, T. Jeffreys, C. Clarke (London, United Kingdom)

    Objective: To evaluate the clinical effectiveness of two speech and language therapy (SLT) approaches compared to no SLT (control) for people with Parkinson’s disease (PD).…
  • 2022 International Congress

    Speech disorders and axial motor impairment in advanced Parkinson’s Disease: two sides of the same coin?

    G. Di Rauso, C. Budriesi, F. Cavallieri, A. Gessani, S. Coniglio, V. Rispoli, F. Valzania, F. Antonelli (Modena, Italy)

    Objective: To examine possible correlations between axial motor features, disease severity and speech parameters in advanced Parkinson’s Disease (PD) patients and to evaluate chronic dopaminergic…
  • 2022 International Congress

    A One-year follow-up study of effects of voltage/frequency Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) adjustments on speech intelligibility in Parkinson’s Disease (PD)

    N. Castillo-Triana, M. Camargo-Mendoza, O. Bernal-Pacheco (Bogotá, Colombia)

    Objective: To assess the relationship between along-1-year stimulation voltage(V)/frequency(F) adjustments and speech intelligibility (SI) in PD patients treated with STN-DBS. Background: Low V/F stimulation improves…
  • 2022 International Congress

    Long-term effects of bilateral STN-DBS on speech in Parkinson’s disease patients

    F. Cavallieri, A. Gessani, V. Fioravanti, B. Damiano, S. Scaltriti, E. Bardi, M. Corni, F. Antonelli, V. Rispoli, G. Di Rauso, F. Cavalleri, M. Molinari, S. Contardi, E. Menozzi, S. Meletti, G. Biagini, E. Moro, A. Merlo, I. Campanini, C. Budriesi, F. Valzania (Reggio Emilia, Italy)

    Objective: To evaluate the long-term effects of bilateral STN-DBS on speech in advanced Parkinson’s disease (PD) patients. Background: Bilateral STN-DBS is an effective treatment in…
  • 2022 International Congress

    Assessment of the long-term effects of STN-DBS on axial symptoms in PD patients through a standardized clinical-instrumental approach

    F. Cavallieri, I. Campanini, A. Gessani, V. Fioravanti, B. Damiano, S. Scaltriti, E. Bardi, M. Corni, F. Antonelli, V. Rispoli, G. Di Rauso, F. Cavalleri, M. Molinari, S. Contardi, E. Menozzi, S. Meletti, G. Biagini, E. Moro, C. Budriesi, A. Merlo, F. Valzania (Reggio Emilia, Italy)

    Objective: To evaluate the long-term effects of bilateral STN-DBS and levodopa on axial symptoms in PD patients and the possible correlations between speech and gait…
  • 2022 International Congress

    Telemedicine in speech and swallowing disorders for patients with Parkinson’s disease: Motivation and satisfaction of patients and speech language pathologists

    Y. Manor, D. Shpunt, A. Zait, A. Ezra, N. Hezi, L. Jokel, H. First, N. Karin, M. Zirler, M. Kalish, L. Raif, A. Migirov Sandrovitz, T. Gurevich1 (Tel Aviv-Yafo, Israel)

    Objective: To assess the satisfaction with telemedicine for speech and swallowing disorders among patients with PD and speech language pathologists (SLP) as well as the…
  • MDS Virtual Congress 2021

    A French national multicentric prospective study of the 1-year impact of STN-DBS on speech in Parkinson’s disease: profile of progression and prognostic factors.

    T. Ollivier, S. Pinto, R. Viard, G. Kuchcinski, G. Touzet, L. Defebvre, D. Devos, C. Moreau (Lille, France)

    Objective: 1) To describe the evolution of speech in a large cohort of patients before and 1 year after STN-DBS. 2) To search for preoperative…
  • MDS Virtual Congress 2021

    Longitudinal Speech Changes In PD and the Relationship to Limb Bradykinesia and Rigidity

    R. Richter, S. Gutierrez, R. Bennett, C. Deckelman, F. Docters, A. Lang, D. Breen, C. Marras, M. Masellis, D. Grimes, M. Jog, B. Tan, K. Sunderland, JB. Orange, P. Mclaughlin, A. Troyer, B. Levine, D. Beaton, M. Binns, D. Munoz, R. Swartz, A. Roberts (Evanston, USA)

    Objective: We tested the assumption that speech diadochokinesis (DDK) in Parkinson’s disease (PD) parallels motor system performances by evaluating DDK changes over 12-months and testing if DDK performance predicts limb bradykinesia and rigidity UPDRS scores. Background: Studies showing that speech DDK correlates with…
  • MDS Virtual Congress 2021

    SPEECH BIOMARKERS IN HEREDITARY SPASTIC PARAPLEGIA

    M. Olchik, L. Scudeiro, V. Dos Santos, A. Ayres, R. Rech, D. Burguêz, G. Machado, C. González-Salazar, M. Padovani, M. França Junior, J. Saute (Porto Alegre, Brazil)

    Objective: To evaluate the frequency and clinical characterization of dysarthria in different types of HSP. Background: Hereditary spastic paraplegias (HSP) are a group of genetic…
  • MDS Virtual Congress 2021

    EVALUATION OF MOTOR SPEECH DISORDERS IN PATIENTS WITH PARKINSON’S DISEASES.

    J. Santos, M. Olchik, R. Rech, I. Klein, A. Bertodo (Porto Alegre, Brazil)

    Objective: To correlate auditory-perceptual assessment and the patient self-perception in speech disorders in Parkison’s Disease and correlate them with clinical data.To correlate auditory-perceptual assessment and…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 16
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley